- Participants must have a diagnosis of asthma. In addition, participants must have persistent asthma as defined by NAEPP guidelines: asthma symptoms > 2 days; > 3 to 4 nighttime awakenings; SABA use >2 days/week; pre-bronchodilator % predicted >60%; FEV1/FVC normal or reduced by 5%.